US Patent Issued to SEEKYO, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE on Nov. 4 for "Therapeutic vectors and prodrugs for treating cancers" (French Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,928, issued on Nov. 4, was assigned to SEEKYO (Futuroscope, France) and CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris).

"Therapeutic vectors and prodrugs for treating cancers" was invented by Sebastien Papot (Poitiers, France), Brigitte Renoux (Nouaille Maupertuis, France) and Remi Chatre (Poitiers, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a compound having the following formula (I):as well as the corresponding prodrugs, pharmaceutical compositions comprising said compounds, in particular for treating cancer."

The patent was filed on May 6, 2020, under Application No. 17/595,012.

*For further info...